TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
OPT

Opthea Ltd

Healthcare · Biotechnology

3.40$ +7.2% vs. previous close Closing price · As of: Jul 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow OPT
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
– – – – – – -21,498.5% -5,650.7% -66,381.5% -78,664.1% -111,256.2% -129,157.4%
– – – – – – 29.4% 95.9% 155.5% 86.4% 93.4% 82.9%
– – – – – – 609.3% 502.2% 4,237.4% 4,199.7% 3,620.4% 4,078.6%
– – – – – – -1,699.0% 5,198.7% 17,182.7% 5,389.5% 4,875.0% –
– – – – – – -1,241.7% 53.6% -23,484.3% 16,171.4% 12,872.7% 13,931.6%
– – – – – – 16.1% 2.5% 18.5% 18.6% 20.3% 26.9%
– – – – – – 285.3% 330.9% 956.8% -18.6% -20.3% -26.9%
– – – – – – -89.1% -68.7% -95.0% -68.4% 52,387.4% –
– – – – – – 11,226.8% 32,942.6% 170,429.4% 189.2% 154,313.6% 195,505.5%
– – – – – – -9,756.1% 27,598.7% 103,731.3% -73,995.7% 42,865.5% 66,804.6%
– – – – – – -21,514.6% -5,653.2% -66,400.0% -78,682.7% -111,276.5% -129,184.3%

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?